+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Expectorant"

Cough and Cold Preparations Global Market Report 2024 - Product Thumbnail Image

Cough and Cold Preparations Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Chronic Cough Global Market Report 2024 - Product Thumbnail Image

Chronic Cough Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Ventorlin Expectorant - API Insight, 2022 - Product Thumbnail Image

Ventorlin Expectorant - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Ventorlin Expectorant- Drug Insight, 2019 - Product Thumbnail Image

Ventorlin Expectorant- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Loading Indicator

Expectorants are a type of cough and cold drug used to treat chest congestion. They work by thinning and loosening mucus in the airways, making it easier to cough up and expel. Expectorants are often used in combination with other medications, such as decongestants, to provide relief from symptoms of the common cold. They are available in both over-the-counter and prescription forms. Expectorants are generally considered safe for use in adults and children over the age of two. However, they should be used with caution in people with certain medical conditions, such as asthma, chronic bronchitis, and heart disease. Some of the companies in the expectorant market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more